3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
45
Colorectal Neoplasms
45
Esophageal Neoplasms
28
Esophageal Squamous Cell Carcinoma
24
Stomach Neoplasms
22
Pancreatic Neoplasms
19
Colonic Neoplasms
18
Adenocarcinoma Of Esophagus
15
Carcinoma, Hepatocellular
14
Neoplasm Metastasis
7
Liver Neoplasms
6
Cholangiocarcinoma
5
Recurrence
4
Locally Advanced Rectal Cancer
4
Turcot syndrome
3
Peritoneal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Breast Neoplasms
2
Bites and Stings
2
Adenocarcinoma
2
Surgery
1
Successful Conversion Rate of Operation
1
Radiation Injuries
1
QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Ductal Adenocarcinoma
1
Interventions
Sorafenib
5
lenvatinib
3
sintilimab
2
pembrolizumab
2
halofantrine
2
camrelizumab
2
atezolizumab
2
Immunotherapy
2
Blood Specimen Collection
2
Bevacizumab
2
Antibodies
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
titanium silicide
1
tislelizumab
1
linifanib
1
genexol-PM
1
gadolinium ethoxybenzyl DTPA
1
fluorocholine
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
bavituximab
1
avelumab
1
User-Centered Design
1
Sunitinib
1
Sufentanil
1
Standard of Care
1
Shadowing Technique, Histology
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Diseases
×
Neoadjuvant Therapy
×
Gastrointestinal
×
Clear all
NCT04727307
2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2
Recruiting
202 enrolled